Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicentre Randomized Double-blind Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis

NCT03580733 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.

NCT NCT03580733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03580733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicentre Randomized Double-blind Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2019
Completion date
December 4, 2024
Enrollment
448 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

icu yeast intra-abdominal infection